Search
for

    Research 10 of 48

    1. Clinical perspective on management of key adverse events with sacituzumab govitecan The Oncologist · 2025 · 1 citations
    2. 3P's (Pharmacokinetic, Pharmacodynamic, and Pharmacogenomic) of Valproate: What's New? International Journal of Pharmaceuticals Nutraceuticals and Cosmetic Science · 2023
    3. Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen Journal of Personalized Medicine · 2026
    4. Evaluation of Personalized Skincare Through in-silico Gene Interactive Networks and Cellular Responses to UVR and Oxidative Stress Clinical Cosmetic and Investigational Dermatology · 2022 · 11 citations
    5. The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy Frontiers in Pharmacology · 2024
    6. Role of skin enzymes in metabolism of topical drugs Metabolism and Target Organ Damage · 2024 · 6 citations
    7. The Rotterdam Study: 2018 update on objectives, design and main results European Journal of Epidemiology · 2017 · 359 citations
    8. The Rotterdam Study: 2016 objectives and design update European Journal of Epidemiology · 2015 · 336 citations
    9. Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations Scientific reports · 2018 · 58 citations
    10. Bioavailability File: Bicalutamide Fabad Journal of Pharmaceutical Sciences · 2025
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →